GlassScriptPhysician profile
Victoria Roed
NPI 1770126229
$1,334.26
in general payments reported to CMS, 2019-2025
18 companies · $379 in 2025
The $379 reported for 2025 was more than what 89% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $271 · 2022: $202 · 2023: $246 · 2024: $237 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $314.67 | 2022-2025 | Doc Band |
| Pfizer INC. | $194.48 | 2021-2025 | |
| Glaxosmithkline, LLC. | $135.55 | 2021-2025 | Bexsero, Pediarix, Menveo |
| Takeda Pharmaceuticals U.S.A., INC. | $129.54 | 2021 | |
| Seqirus USA INC | $82.31 | 2021-2025 | Flucelvax, Flucelvax Quadrivalent, Fluad |
| Sanofi Pasteur INC. | $75.67 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $61.81 | 2025 | |
| Merck Sharp & Dohme LLC | $58.60 | 2023-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Aytu Biopharma, INC. | $55.65 | 2022-2024 | Karbinal |
| Alk-Abello, INC | $41.68 | 2025 | Ragwitek, Odactra, Grastek |
| Phadia US INC. | $36.64 | 2022-2025 | Immunocap |
| Neos Therapeutics, LP | $34.52 | 2021-2022 | |
| Sobi, INC | $27.58 | 2021 | |
| Hologic Sales and Service, LLC | $24.83 | 2025 | Aptima |
| Aimmune Therapeutics, INC. | $21.11 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $15.22 | 2025 | Zoryve |
| Alexion Pharmaceuticals, INC. | $12.77 | 2023 | Strensiq |
| Organon LLC | $11.63 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Roed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.